250 related articles for article (PubMed ID: 1330157)
21. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
Shenker A; Maayani S; Weinstein H; Green JP
Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems.
Schoeffter P; Bobirnac I; Boddeke E; Hoyer D
Neuropharmacology; 1997; 36(4-5):429-37. PubMed ID: 9225266
[TBL] [Abstract][Full Text] [Related]
23. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
Jerning E; Rosqvist S; Mohell N
J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
[TBL] [Abstract][Full Text] [Related]
24. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
25. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs.
Inoue M; Kitazawa T; Cao J; Taneike T
Eur J Pharmacol; 2003 Feb; 461(2-3):207-18. PubMed ID: 12586216
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.
Schoeffter P; Bobirnac I
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):256-62. PubMed ID: 8584040
[TBL] [Abstract][Full Text] [Related]
28. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
29. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
30. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
Lanfumey L; Haj-Dahmane S; Hamon M
Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
[TBL] [Abstract][Full Text] [Related]
31. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
32. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
33. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
Parsons AA; Motevalian M; Whalley ET
Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
[TBL] [Abstract][Full Text] [Related]
34. S 14506: novel receptor coupling at 5-HT(1A) receptors.
Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
36. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors.
Soares-da-Silva P; Pinto-do-O PC; Bertorello AM
Br J Pharmacol; 1996 Mar; 117(6):1199-203. PubMed ID: 8882616
[TBL] [Abstract][Full Text] [Related]
38. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
39. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
[TBL] [Abstract][Full Text] [Related]
40. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]